Dr. Sanober Kable, MD
What this data tells you about Dr. Kable
Dr. Sanober Kable is a critical care medicine in Denison, TX, with 19 years in practice. Based on federal Medicare data, Dr. Kable performed 40,935 Medicare services across 4,921 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kable received a total of $239,350 from 58 pharmaceutical and/or device companies across 1728 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kable is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Omalizumab injection (Xolair) for asthma/allergy | 17,117 | $30 | $40 |
| Injection, mepolizumab, 1 mg | 14,270 | $23 | $60 |
| Injection, benralizumab, 1 mg | 1,740 | $132 | $250 |
| Office visit, established patient (30-39 min) | 1,327 | $93 | $210 |
| Drug injection, under skin or into muscle | 974 | $11 | $79 |
| Allergy skin test | 937 | $3 | $10 |
| Office visit, established patient (20-29 min) | 690 | $65 | $150 |
| Test to examine how well the lungs exchange gases | 660 | $41 | $149 |
| Test to determine lung volumes using sensors | 631 | $39 | $150 |
| Test for exercise-induced lung stress | 549 | $24 | $100 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 449 | $28 | $150 |
| Hospital follow-up visit, moderate complexity | 284 | $59 | $140 |
| Test to measure expiratory airflow and volume | 221 | $20 | $100 |
| New patient office visit (45-59 min) | 201 | $123 | $320 |
| New patient office visit (30-44 min) | 140 | $78 | $210 |
| Injection, methylprednisolone acetate, 20 mg | 130 | $4 | $30 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 89 | $14 | $600 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 85 | $95 | $889 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 82 | $94 | $700 |
| Initial hospital admission, moderate complexity | 68 | $95 | $270 |
| Sleep study in sleep lab (6 years or older) | 64 | $90 | $240 |
| Ceftriaxone antibiotic injection | 42 | $0 | $35 |
| Hospital follow-up visit, high complexity | 35 | $92 | $205 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 32 | $125 | $1,125 |
| Sleep study including heart rate, breathing, airflow, and effort | 26 | $66 | $456 |
| Exam of lung airways using an endoscope | 25 | $8 | $479 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 24 | $73 | $1,998 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 20 | $54 | $200 |
| Insertion of tube in right heart chambers for measurement | 12 | $98 | $1,470 |
| Initial hospital admission, high complexity | 11 | $134 | $400 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in critical care medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for critical care medicine in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kable is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kable experienced with omalizumab injection (xolair) for asthma/allergy?
Does Dr. Kable receive payments from pharmaceutical companies?
How do Dr. Kable's costs compare to other critical care medicines in Denison?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology